skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 94  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: subject: Overweight - Complications remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
Material Type:
Article 		Add to My Research

Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

Nature medicine, 2022-10, Vol.28 (10), p.2083-2091 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-022-02026-4 ;PMID: 36216945

Full text available

Citations Cited by
2
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
Material Type:
Article 		Add to My Research

Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study

Diabetes care, 2021-06, Vol.44 (6), p.1433-1442 [Peer Reviewed Journal]

2021 by the American Diabetes Association. ;Copyright American Diabetes Association Jun 1, 2021 ;2021 by the American Diabetes Association 2021 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-2151 ;PMID: 34016612

Full text available

Citations Cited by
3
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
Material Type:
Article 		Add to My Research

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

The New England journal of medicine, 2018-09, Vol.379 (12), p.1107-1117 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1808721 ;PMID: 30145941

Full text available

Citations Cited by
4
Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome
Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome
Material Type:
Article 		Add to My Research

Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome

The journal of clinical endocrinology and metabolism, 2015-11, Vol.100 (11), p.4048-4058 [Peer Reviewed Journal]

Copyright © 2015 by the Endocrine Society ;Copyright © 2015 by The Endocrine Society ;Copyright © 2015 by the Endocrine Society 2015 ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/jc.2015-2778 ;PMID: 26401593

Full text available

Citations Cited by
5
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
Material Type:
Article 		Add to My Research

Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial

Diabetes care, 2020-05, Vol.43 (5), p.1085-1093 [Peer Reviewed Journal]

2020 by the American Diabetes Association. ;Copyright American Diabetes Association May 1, 2020 ;2020 by the American Diabetes Association 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc19-1745 ;PMID: 32139381

Full text available

Citations Cited by
6
Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
Material Type:
Article 		Add to My Research

Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes

Diabetes care, 2013-12, Vol.36 (12), p.4022-4029 [Peer Reviewed Journal]

2015 INIST-CNRS ;COPYRIGHT 2013 American Diabetes Association ;Copyright American Diabetes Association Dec 2013 ;2013 by the American Diabetes Association. 2013 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc13-0234 ;PMID: 24144653 ;CODEN: DICAD2

Full text available

Citations Cited by
7
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
Material Type:
Article 		Add to My Research

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

The American journal of clinical nutrition, 2012-02, Vol.95 (2), p.297-308 [Peer Reviewed Journal]

2012 American Society for Nutrition. ;2015 INIST-CNRS ;Copyright American Society for Clinical Nutrition, Inc. Feb 1, 2012 ;ISSN: 0002-9165 ;EISSN: 1938-3207 ;DOI: 10.3945/ajcn.111.024927 ;PMID: 22158731 ;CODEN: AJCNAC

Full text available

Citations Cited by
8
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics
Material Type:
Article 		Add to My Research

Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics

Obesity (Silver Spring, Md.), 2023-01, Vol.31 (1), p.111-122 [Peer Reviewed Journal]

2022 The Authors. published by Wiley Periodicals LLC on behalf of The Obesity Society. ;2022 The Authors. Obesity published by Wiley Periodicals LLC on behalf of The Obesity Society. ;Copyright Blackwell Publishing Ltd. Jan 2023 ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1002/oby.23621 ;PMID: 36502289

Full text available

Citations Cited by
9
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials
Material Type:
Article 		Add to My Research

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

BMJ, 2012-01, Vol.344 (7841), p.14-14 [Peer Reviewed Journal]

Vilsbøll et al 2012 ;BMJ Publishing Group Ltd 2012 ;Copyright: 2012 © Vilsbøll et al 2012 ;Vilsbøll et al 2012 2012 Vilsbøll et al ;ISSN: 0959-8138 ;EISSN: 1468-5833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.d7771 ;PMID: 22236411

Full text available

Citations Cited by
10
A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
Material Type:
Article 		Add to My Research

A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial

The journal of clinical endocrinology and metabolism, 2011-10, Vol.96 (10), p.3067-3077 [Peer Reviewed Journal]

Copyright © 2011 by The Endocrine Society ;2015 INIST-CNRS ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/jc.2011-1256 ;PMID: 21795446 ;CODEN: JCEMAZ

Full text available

Citations Cited by
11
Effects of Semaglutide on Albuminuria and Kidney Function in People With Overweight or Obesity With or Without Type 2 Diabetes: Exploratory Analysis From the STEP 1, 2, and 3 Trials
Effects of Semaglutide on Albuminuria and Kidney Function in People With Overweight or Obesity With or Without Type 2 Diabetes: Exploratory Analysis From the STEP 1, 2, and 3 Trials
Material Type:
Article 		Add to My Research

Effects of Semaglutide on Albuminuria and Kidney Function in People With Overweight or Obesity With or Without Type 2 Diabetes: Exploratory Analysis From the STEP 1, 2, and 3 Trials

Diabetes care, 2023-04, Vol.46 (4), p.801-810 [Peer Reviewed Journal]

2023 by the American Diabetes Association. ;Copyright American Diabetes Association Apr 2023 ;2023 by the American Diabetes Association 2023 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc22-1889 ;PMID: 36801984

Full text available

Citations Cited by
12
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
Material Type:
Article 		Add to My Research

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

The New England journal of medicine, 2010-09, Vol.363 (10), p.905-917 [Peer Reviewed Journal]

Copyright © 2010 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1003114 ;PMID: 20818901 ;CODEN: NEJMAG

Full text available

Citations Cited by
13
Optimal dosing of enoxaparin in overweight and obese children
Optimal dosing of enoxaparin in overweight and obese children
Material Type:
Article 		Add to My Research

Optimal dosing of enoxaparin in overweight and obese children

British journal of clinical pharmacology, 2022-12, Vol.88 (12), p.5348-5358 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. ;2022 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. ;ISSN: 0306-5251 ;EISSN: 1365-2125 ;DOI: 10.1111/bcp.15459 ;PMID: 35816401

Full text available

Citations Cited by
14
How to Dose Vancomycin in Overweight and Obese Patients with Varying Renal (Dys)function in the Novel Era of AUC 400–600 mg·h/L-Targeted Dosing
How to Dose Vancomycin in Overweight and Obese Patients with Varying Renal (Dys)function in the Novel Era of AUC 400–600 mg·h/L-Targeted Dosing
Material Type:
Article 		Add to My Research

How to Dose Vancomycin in Overweight and Obese Patients with Varying Renal (Dys)function in the Novel Era of AUC 400–600 mg·h/L-Targeted Dosing

Clinical pharmacokinetics, 2024, Vol.63 (1), p.79-91 [Peer Reviewed Journal]

The Author(s) 2023 ;ISSN: 0312-5963 ;EISSN: 1179-1926 ;DOI: 10.1007/s40262-023-01324-5

Digital Resources/Online E-Resources

Citations Cited by
15
A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity
A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity
Material Type:
Article 		Add to My Research

A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity

Nature communications, 2023-12, Vol.14 (1), p.8289-8289, Article 8289 [Peer Reviewed Journal]

2023. The Author(s). ;The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-023-44067-4 ;PMID: 38092790

Full text available

Citations Cited by
16
Glucagon‐like peptide‐1/glucagon receptor agonism associates with reduced metabolic adaptation and higher fat oxidation: A randomized trial
Glucagon‐like peptide‐1/glucagon receptor agonism associates with reduced metabolic adaptation and higher fat oxidation: A randomized trial
Material Type:
Article 		Add to My Research

Glucagon‐like peptide‐1/glucagon receptor agonism associates with reduced metabolic adaptation and higher fat oxidation: A randomized trial

Obesity (Silver Spring, Md.), 2023-02, Vol.31 (2), p.350-362 [Peer Reviewed Journal]

2023 The Obesity Society. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA. ;Copyright Blackwell Publishing Ltd. Feb 2023 ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1002/oby.23633 ;PMID: 36695055

Full text available

Citations Cited by
17
Coadministration of Canagliflozin and Phentermine for Weight Management in Overweight and Obese Individuals Without Diabetes: A Randomized Clinical Trial
Coadministration of Canagliflozin and Phentermine for Weight Management in Overweight and Obese Individuals Without Diabetes: A Randomized Clinical Trial
Material Type:
Article 		Add to My Research

Coadministration of Canagliflozin and Phentermine for Weight Management in Overweight and Obese Individuals Without Diabetes: A Randomized Clinical Trial

Diabetes care, 2017-05, Vol.40 (5), p.632-639 [Peer Reviewed Journal]

2017 by the American Diabetes Association. ;Copyright American Diabetes Association May 2017 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc16-2427 ;PMID: 28289041

Full text available

Citations Cited by
18
Effects of Liraglutide on Heart Rate and Heart Rate Variability: A Randomized, Double-Blind, Placebo-Controlled Crossover Study
Effects of Liraglutide on Heart Rate and Heart Rate Variability: A Randomized, Double-Blind, Placebo-Controlled Crossover Study
Material Type:
Article 		Add to My Research

Effects of Liraglutide on Heart Rate and Heart Rate Variability: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

Diabetes care, 2017-01, Vol.40 (1), p.117-124 [Peer Reviewed Journal]

2017 by the American Diabetes Association. ;Copyright American Diabetes Association Jan 1, 2017 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc16-1580 ;PMID: 27797930 ;CODEN: DICAD2

Full text available

Citations Cited by
19
Safety and tolerability of high-dose daily vitamin D 3 supplementation in the vitamin D and type 2 diabetes (D2d) study-a randomized trial in persons with prediabetes
Safety and tolerability of high-dose daily vitamin D 3 supplementation in the vitamin D and type 2 diabetes (D2d) study-a randomized trial in persons with prediabetes
Material Type:
Article 		Add to My Research

Safety and tolerability of high-dose daily vitamin D 3 supplementation in the vitamin D and type 2 diabetes (D2d) study-a randomized trial in persons with prediabetes

European journal of clinical nutrition, 2022-08, Vol.76 (8), p.1117 [Peer Reviewed Journal]

2022. The Author(s). ;EISSN: 1476-5640 ;DOI: 10.1038/s41430-022-01068-8 ;PMID: 35140313

Full text available

Citations Cited by
20
11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension
11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension
Material Type:
Article 		Add to My Research

11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension

The journal of clinical endocrinology and metabolism, 2021-01, Vol.106 (1), p.174-187 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. 2020 ;Copyright © Oxford University Press 2015 ;The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/clinem/dgaa766 ;PMID: 33098644

Full text available

Citations Cited by

Results 1 - 20 of 94  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (86)

Refine My Results

Creation Date 

From To
Refine
  1. Before 2010  (7)
  2. 2010 To 2012  (13)
  3. 2013 To 2015  (12)
  4. 2016 To 2019  (25)
  5. After 2019  (38)
  6. More options open sub menu

Language 

  1. English  (93)
  2. Japanese  (7)
  3. Italian  (1)
  4. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait